Related Experiment Video
Updated: Jul 2, 2026

12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
18.3K
Association between Hashimoto's thyroiditis and melanoma: a retrospective matched cohort study
B G Gorman1,2, E Campbell3, B L Mullen4
1Mayo Clinic Alix School of Medicine, 200 First Street SW, Rochester, MN, 55905, USA. gorman.benjamin@mayo.edu.
Archives of Dermatological Research
|July 21, 2023
Summary
This study investigated if Hashimoto's thyroiditis increases melanoma risk. Results show no significant difference in melanoma development for patients with Hashimoto's thyroiditis compared to controls.
Area of Science:
- Dermatology
- Endocrinology
- Autoimmunity
Background:
- An inflammatory microenvironment is linked to increased malignant melanoma risk.
- Hashimoto's thyroiditis is a common autoimmune condition with a pro-inflammatory component.
- The relationship between Hashimoto's thyroiditis and melanoma risk is not well-understood.
Purpose of the Study:
- To determine if a diagnosis of Hashimoto's thyroiditis increases the risk of developing melanoma.
- To investigate the association between Hashimoto's thyroiditis and the incidence of melanoma.
Main Methods:
- Retrospective cohort study utilizing the Olmsted County database.
- Inclusion criteria: patients diagnosed with Hashimoto's thyroiditis between 2005 and 2020.
- Age and sex-matched controls without Hashimoto's thyroiditis were compared for melanoma development.
Main Results:
- A cohort of 4805 patients was analyzed, with 1726 diagnosed with Hashimoto's thyroiditis.
- Patients with Hashimoto's thyroiditis showed no significant difference in melanoma risk (RR 0.96, 95% CI 0.78-1.17).
- No significant difference was observed in nonmelanoma skin cancer risk (RR 0.95, 95% CI 0.86-1.06).
Conclusions:
- The pro-inflammatory environment associated with Hashimoto's thyroiditis does not appear to significantly increase melanoma risk.
- Further research with larger cohorts may be necessary to fully elucidate the relationship between these conditions.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

